Medendi

📍 Modena, Italy👥 6 employees💰 Last funded Dec 2023
Medendi gives patients a deep understanding of their specific tumor profile and identifies and advises the most effective targeted treatment options available, including worldwide clinical trials, when appropriate. The Medendi process is totally online, paperless, and quick. In one month from on boarding the patient will be advised with the best available treatment options, provided by the most qualified health structures network. The Journey. Analysis: an expert, from the Medendi Scientific Committee, analyzes the patient’s clinical documentation and evaluates whether genomic profiling is needed or, alternatively, the patient would benefit from a second opinion. Genetic Testing: to identify the best available treatment, the tumor is profiled with the most advanced genetic tests to scan for tumor genomic alterations. Recommendation: the expert advises the patient with the best therapeutic options available worldwide, including molecules and drugs in clinical trial; Medendi, thanks to its global network and online DBs, is up to date with the most qualified medical centers, the new drugs and molecules researched and the ongoing clinical trials. Treatment: Medendi supports the patients in the therapy phase: accessing the selected medical center and the best specialists, providing the most appropriate treatment, managing documentation, and eventually supporting the patient and the family for trip and accommodation.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Medendi?
Medendi has 1 investors on record on gritt.io.
When did Medendi last raise funding?
The most recent investment in Medendi recorded on gritt.io was in December 2023.
What industry is Medendi in?
Medendi operates in Medical Practices. Find similar Medical Practices investors on gritt.io.
Where is Medendi based?
Medendi is headquartered in Modena, Italy.